Latest news
Small NZ drugmaker quietly outperforms global giants Pfizer and Merck - NewsroomNewsroom · Sun, 02 Aug 2026 17:00:00 GMTAFT Pharmaceuticals Chair David Flacks to Retire Within 12 Months as Revenue Hits $254.7 Million - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Chair David Flacks to Step Down Within a Year as Revenue Surges to $254.7 Million - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Reports 22% Revenue Growth to $254.7 Million, Lifts Dividend to 2.5 Cents - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAFT Pharmaceuticals Sees 22% Revenue Surge to $254.7M, Boosts Dividend to 2.5 Cents - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 06:01:14 GMT‘An incredible journey’ says retiring AFT chair David Flacks - National Business ReviewNational Business Review · Fri, 31 Jul 2026 02:55:07 GMTAFT Pharmaceuticals Chair to Retire - MoomooMoomoo · Thu, 30 Jul 2026 22:31:39 GMTAFT chair David Flacks to retire after 12 years - BusinessDesk | NZBusinessDesk | NZ · Thu, 30 Jul 2026 22:05:02 GMT